A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)

Name: A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)
Published: 2026
License: Public Domain

GlaxoSmithKline · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

alcohol liverdiseases

liver diseases, alcoholic, efimosfermin alfa, alcohol-related liver disease, liver stiffness measurement, advanced chronic liver disease, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)

Related documents